In- VitroComparative Activity of Fluconazole and Other Antifungal Agents AgainstBlastoschizomyces capitatus
- 1 February 1991
- journal article
- research article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 3 (1) , 13-15
- https://doi.org/10.1080/1120009x.1991.11739056
Abstract
Summary Blastoschizomyces caphatus represents an emerging fungal pathogen in acute leukemia patients. The susceptibility to amphotericin B, 5-fluorocytosine, ketoconazole and fluconazole of nine clinical isolates was evaluated. A specific medium (high resolution medium) was used for testing fluconazole. This agent and 5-fluorocytosine were at least four- to eightfold more active than amphotericin B and ketoconazole against all isolates but one.Keywords
This publication has 10 references indexed in Scilit:
- Blastoschizomyces capitatus: An Emerging Cause of Invasive Fungal Disease in Leukemia PatientsClinical Infectious Diseases, 1990
- Fungal InfectionsCurrent Opinion in Infectious Diseases, 1989
- Treatment of systemic fungal infections: Recent progress and current problemsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Azole antifungal agents: emphasis on new triazolesAntimicrobial Agents and Chemotherapy, 1988
- Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivoAntimicrobial Agents and Chemotherapy, 1986
- Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humansAntimicrobial Agents and Chemotherapy, 1985
- A microautomated dilution method for susceptibility testing with antifungal drugsMycopathologia, 1984
- Influence of food on the pharmacokinetics of ketoconazoleAntimicrobial Agents and Chemotherapy, 1984
- Variability of Agar Dilution-Replicator Method of Yeast Susceptibility TestingAntimicrobial Agents and Chemotherapy, 1979
- Antimicrobial Susceptibility Testing of Yeasts: a Turbidimetric Technique Independent of Inoculum SizeAntimicrobial Agents and Chemotherapy, 1976